Dermatophytic Onychomycosis Treatment Market Growth Rate Analysis 2026

1. Dermatophytic Onychomycosis Treatment Dermatophytic Onychomycosis Treatment Market Size, Share, Trend, Outlook, Future Market Size, Share, Trend, Outlook, Future Growth Analysis And Synthesis 2018 - 2026 Growth Analysis And Synthesis 2018 - 2026 Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails. Trichophyton rubrum and trichophyton mentagrophytes are common strains of fungi responsible for causing dermatophytic onychomycosis. Furthermore, yeasts and non-dermatophyte molds are other agents that spread the infection. Public places such as gym, swimming pool, and others that are infected with disease causing fungal agents are major source, which cause dermatophytic onychomycosis. Moreover, continuous use of shoes for a longer duration and contact of toe nail with wet surface causes the fungal infection. Increasing incidences of the infection are evident in sportsperson, owing to continuous use of shoe, sweating at nails, and traumatic nail injuries. Request Free Sample Copy @ Request Free Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2053 https://www.coherentmarketinsights.com/insight/request-sample/2053 Major symptoms of dermatophytic onychomycosis include thickening and whitening of nails. Moreover, the nails become brittle and appear white as the infection progresses. People suffering from diabetes, peripheral vascular disease, HIV, immune suppression, obesity, and geriatric population are at increased risk of this common fungal infection. Dermatophytic onychomycosis could be treated with either topical preparations or oral antifungal agents based on the severity of infection. The treatment often lasts for an average period of six months. In recent past, advancement in therapy with the introduction of effective topical and oral products has controlled the rapid spread of dermatophytic onychomycosis. The global dermatophytic onychomycosis treatment market size was valued at US$ 2,596.8 million in The global dermatophytic onychomycosis treatment market size was valued at US$ 2,596.8 million in 2017, and is expected to witness a CAGR of 12.6% over the forecast period (2018 – 2026). 2017, and is expected to witness a CAGR of 12.6% over the forecast period (2018 – 2026). Increased global prevalence of dermatophytic onychomycosis is expected to propel growth of the Increased global prevalence of dermatophytic onychomycosis is expected to propel growth of the dermatophytic onychomycosis treatment market dermatophytic onychomycosis treatment market

2. Dermatophytic onychomycosis is most common nail disorder. According to a report in the Journal of Cutaneous Medicine and Surgery, 2017, onychomycosis accounts for 50% of all nail diseases and prevalence of onychomycosis was estimated to be 5.5% with margin of error of + 3% worldwide. Prophylactic use of topical antifungal agent is expected to aid in effective treatment of dermatophytic onychomycosis, which in turn is major factor contributing to the market growth. Development of new therapies that aid in treatment of dermatophytic onychomycosis is expected to drive Development of new therapies that aid in treatment of dermatophytic onychomycosis is expected to drive growth of the dermatophytic onychomycosis treatment market over the forecast period growth of the dermatophytic onychomycosis treatment market over the forecast period Introduction of new drug candidates and adoption of new treatment approaches is a major factor contributing to the dermatophytic onychomycosis treatment market growth. For instance, in 2014, the U.S. Food and Drug Administration (FDA) approved two new topical antifungal drugs—efinaconazole and tavaborole— for the treatment of dermatophytic onychomycosis caused by Trichophyton rubrum and Trichophyton mentagrophytes. Efinaconazole is the first approved topical triazole antifungal agent and tavaborole is the first approved oxobarole antifungal agent for this indication. These agents offer short treatment courses, high cure rates, and few relapse cases. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Dermatophytic Onychomycosis Treatment Market Research Objective and Assumption • Dermatophytic Onychomycosis Treatment Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Dermatophytic Onychomycosis Treatment Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Dermatophytic Onychomycosis Treatment Market, By Regions • Dermatophytic Onychomycosis Treatment Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Dermatophytic Onychomycosis Treatment Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Dermatophytic Onychomycosis Treatment Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change.

3. • Dermatophytic Onychomycosis Treatment Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Global Dermatophytic Onychomycosis Treatment Market Key Players Global Dermatophytic Onychomycosis Treatment Market Key Players Key players operating in the dermatophytic onychomycosis treatment market include, Bausch Health Companies, Galderma S.A., Celtic Pharma, Anacor pharmaceuticals, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., GlaxoSmithKline, Topica Pharmaceuticals, Inc., Moberg Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd, Allergen, Inc., Cipla Ltd, Medimetriks Pharmaceuticals Inc., Sanofi S.A., NovaBiotics Inc., and Merz Pharma. Detailed Segmentation: Detailed Segmentation: Global Dermatophytic Onychomycosis Treatment Market, By Therapy Type: Systemic Therapy • Topical Therapy • Device-based Therapy • Global Dermatophytic Onychomycosis Treatment Market, By End User: Hospitals • Dermatology Clinics • Retail Pharmacies • Others • Global Dermatophytic Onychomycosis Treatment Market, By Geography: North America • Latin America • Europe • Asia Pacific • Middle East • Africa •

4. Get Full Access of This Business Report: Get Full Access of This Business Report: https://www.coherentmarketinsights.com/market-insight/ https://www.coherentmarketinsights.com/market-insight/ dermatophytic-onychomycosis-treatment-market-2053 dermatophytic-onychomycosis-treatment-market-2053 About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com